Cumulative toxicities from cisplatin therapy and current cytoprotective measures

被引：95
作者：
Cvitkovic, E [1 ]
机构：
[1] Hop Paul Brousse, SMSIT, F-94804 Villejuif, France
来源：
CANCER TREATMENT REVIEWS | 1998年 / 24卷 / 04期
关键词：
D O I：
10.1016/S0305-7372(98)90061-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：265 / 281
页数：17
相关论文
共 276 条
[51]   CISPLATIN NEUROTOXICITY [J].
CERSOSIMO, RJ .
CANCER TREATMENT REVIEWS, 1989, 16 (04) :195-211
[52]   CISPLATIN AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX - A PHASE-II TRIAL [J].
CERVELLINO, JC ;
ARAUJO, CE ;
SANCHEZ, O ;
MILES, H ;
NISHIHAMA, A .
ACTA ONCOLOGICA, 1995, 34 (02) :257-259
[53]   THE COMPARATIVE EFFECTS OF SODIUM THIOSULFATE, DIETHYLDITHIOCARBAMATE, FOSFOMYCIN AND WR-2721 ON AMELIORATING CISPLATIN-INDUCED OTOTOXICITY [J].
CHURCH, MW ;
KALTENBACH, JA ;
BLAKLEY, BW ;
BURGIO, DL .
HEARING RESEARCH, 1995, 86 (1-2) :195-203
[54]   Pantothenic acid and coenzyme A in experimental cisplatin-induced ototoxia [J].
Ciges, M ;
FernandezCervilla, F ;
Crespo, PV ;
Campos, A .
ACTA OTO-LARYNGOLOGICA, 1996, 116 (02) :263-268
[55]  
Clamon GH, 1996, HEAD NECK-J SCI SPEC, V18, P236, DOI 10.1002/(SICI)1097-0347(199605/06)18:3<236::AID-HED5>3.0.CO
[56]  
2-0
[57]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[58]   Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: Unexpected incidence of neurotoxicity [J].
Connelly, E ;
Markman, M ;
Kennedy, A ;
Webster, K ;
Kulp, B ;
Peterson, G ;
Belinson, J .
GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :166-168
[59]   High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: A randomized study of the gruppo oncologico nord-ovest [J].
Conte, PF ;
Bruzzone, M ;
Carnino, F ;
Gadducci, A ;
Algeri, R ;
Bellini, A ;
Boccardo, F ;
Brunetti, I ;
Catsafados, E ;
Chiara, S ;
Foglia, G ;
Gallo, I ;
Iskra, L ;
Mammoliti, S ;
Parodi, G ;
Ragni, N ;
Rosso, R ;
Rugiati, S ;
Rubagotti, A .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :351-356
[60]   NEPHROTOXICITY AND HYDRATION MANAGEMENT FOR CISPLATIN, CARBOPLATIN, AND ORMAPLATIN [J].
CORNELISON, TL ;
REED, E .
GYNECOLOGIC ONCOLOGY, 1993, 50 (02) :147-158
12345678910